Literature DB >> 6573316

Pharmacokinetics and tolerance of a 24-h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers.

H K Adam, H L Houghton, R A Yates, J Young, R J Donnelly.   

Abstract

Cefotetan disodium has been given by zero order intravenous infusion at 75.8 mg/h to four healthy male volunteers over a 24-h period. Plasma concentrations rose until by 12 hs a mean steady state value of 37.5 mg/l was attained. In an additional four volunteers a loading dose of 0.5 g cefotetan was given immediately prior to a similar infusion. In these subjects concentrations in excess of the final steady-state value of 36.2 mg/l were achieved immediately and concentrations never fell below this value for the entire 24-h period of the study. The dose was well tolerated with the exception of an incidence of diarrhoea (2/8 mild and 1/8 severe). The pharmacokinetic findings are in good agreement with theoretical predictions based on single intravenous bolus doses of cefotetan and suggest that a loading dose, followed by an infusion would be suitable regime for cases of severe infection.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6573316     DOI: 10.1093/jac/11.suppl_a.193

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  8 in total

1.  Quantitative measurement of biliary excretion and of gall bladder concentration of drugs under physiological conditions in man.

Authors:  A Lanzini; M G Pigozzi; A Wuhrer; D Facchinetti; M Castellano; L Bettini; U P Guerra; M Beschi; G Muiesan
Journal:  Gut       Date:  1989-01       Impact factor: 23.059

2.  Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers.

Authors:  Meng-xiang Su; Min-hong Liu; Bin Di; Li-li Huang; Yuan Jiang; Peng-cheng Ma; Tai-jun Hang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-09-14       Impact factor: 2.441

3.  Pharmacokinetics and clinical study of cefotetan in bile: prophylactic use in biliary tract surgery.

Authors:  P Cherrier; P Perrin; S Gueye; A M Bosio; P Tinel; P Blot; R Richer; F Fauvelle
Journal:  Pharm World Sci       Date:  1993-04-23

4.  A simple and sensitive liquid chromatographic technique for the determination of cefotetan disodium in human plasma and its application in a pharmacokinetic study.

Authors:  Yani Liu; Jiangeng Huang; Jinmei Liu; Lin Ma; Yongning Lv; Shaojun Shi
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-10-18

Review 5.  Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Richards
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

6.  Cefotetan pharmacokinetics in volunteers with various degrees of renal function.

Authors:  B R Smith; J L LeFrock; P T Thyrum; B A Doret; C Yeh; G Onesti; A Schwartz; J J Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

Review 7.  Clinical pharmacokinetics of cefotetan.

Authors:  C Martin; L Thomachot; J Albanese
Journal:  Clin Pharmacokinet       Date:  1994-04       Impact factor: 6.447

Review 8.  Clinical pharmacokinetics of the third generation cephalosporins.

Authors:  L Balant; P Dayer; R Auckenthaler
Journal:  Clin Pharmacokinet       Date:  1985 Mar-Apr       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.